INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 50 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $18,400,000 | -37.6% | 24,475,000 | -32.7% | 0.02% | -47.5% |
| Q1 2020 | $29,468,000 | -63.3% | 36,360,000 | -54.3% | 0.04% | -45.2% |
| Q4 2019 | $80,207,000 | +14.8% | 79,610,000 | -0.7% | 0.07% | +5.8% |
| Q3 2019 | $69,869,000 | -1.9% | 80,210,000 | 0.0% | 0.07% | +4.5% |
| Q2 2019 | $71,198,000 | -26.0% | 80,210,000 | -17.3% | 0.07% | -30.5% |
| Q1 2019 | $96,216,000 | +17.3% | 96,985,000 | +5.6% | 0.10% | +5.6% |
| Q4 2018 | $82,043,000 | -13.6% | 91,840,000 | -3.1% | 0.09% | +4.7% |
| Q3 2018 | $94,974,000 | +148.1% | 94,760,000 | +118.4% | 0.09% | +132.4% |
| Q2 2018 | $38,287,000 | +11.0% | 43,385,000 | 0.0% | 0.04% | +12.1% |
| Q1 2018 | $34,491,000 | -5.4% | 43,385,000 | -3.3% | 0.03% | +13.8% |
| Q4 2017 | $36,469,000 | +0.9% | 44,885,000 | -3.2% | 0.03% | -6.5% |
| Q3 2017 | $36,157,000 | +823.3% | 46,385,000 | +1059.6% | 0.03% | +675.0% |
| Q2 2017 | $3,916,000 | +5.0% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,728,000 | +3.4% | 4,000,000 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $3,606,000 | -87.0% | 4,000,000 | -83.8% | 0.00% | -88.9% |
| Q3 2016 | $27,754,000 | – | 24,765,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 15,003,000 | $13,500,000 | 6.56% |
| PenderFund Capital Management Ltd. | 9,605,000 | $10,735,000 | 2.51% |
| Silver Point Capital L.P. | 38,808,000 | $34,151,000 | 1.87% |
| Benefit Street Partners LLC | 5,045,000 | $4,440,000 | 1.69% |
| Context Capital Management, LLC | 11,279 | $10,168,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $51,920,000 | 0.92% |
| DeepCurrents Investment Group LLC | 30,292,000 | $27,169,000 | 0.81% |
| Saltoro Capital, LP | 1,800,000 | $1,623,000 | 0.66% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,481,000 | $18,638,000 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 64,548,000 | $58,191,000 | 0.24% |